8-K
filed November 27, 2024, 6:59 PM ET
CIK 0000827871
other material
confidence high
sentiment negative
materiality 0.75
EAGLE PHARMACEUTICALS, INC.: auditor change — Eagle Pharmaceuticals dismisses EY, appoints BDO as auditor amid restatement
EAGLE PHARMACEUTICALS, INC.
- EY dismissed on Nov 21, 2024; BDO engaged on Nov 26, 2024 for FY2022, FY2023, and FY2024 audits.
- Restatement covers FY2022, Q2-Q3 2022, Q1-Q2 2023; later periods delayed due to material weaknesses.
- Material weaknesses in internal control over financial reporting identified, requiring expanded audit procedures.
- No disagreements with EY except for restatement and material weaknesses; EY letter filed as Exhibit 16.1.
- Company's stock delisted from Nasdaq, now trading OTC under symbol EGRX since Oct 4, 2024.
Key facts
Extracted from this filing and checked against the source text.
Auditor Changes
SEC 8-K Item 4.01/4.02
confidence 0.9
EAGLE PHARMACEUTICALS, INC. reported that prior financial statements should not be relied upon.
- Action
- non reliance
- Auditor
- Ernst & Young LLP
Exact text from the filing
on September 27, 2024, the Audit Committee, based on the recommendation of, and after consultation with, the Company’s management, concluded that the Company’s audited financial statements for the fiscal year ended December 31, 2022, and unaudited financial statements for the quarters ended June 30, 2022, September 30, 2022, and March 31, 2023, as previously filed with the SEC, should no longer be relied upon and should be restated.
View on SEC.gov
Auditor Changes
SEC 8-K Item 4.01/4.02
confidence 0.9
EAGLE PHARMACEUTICALS, INC. dismissed Ernst & Young LLP as its auditor.
- Action
- dismissal
- Auditor
- Ernst & Young LLP
Exact text from the filing
On November 21, 2024, Eagle Pharmaceuticals, Inc., a Delaware corporation (the “Company”), dismissed Ernst & Young LLP (“EY”), the Company’s previous independent registered public accounting firm.
View on SEC.gov
Auditor Changes
SEC 8-K Item 4.01/4.02
confidence 0.9
EAGLE PHARMACEUTICALS, INC. engaged BDO USA, P.C. as its auditor.
- Action
- engagement
- Auditor
- BDO USA, P.C.
Exact text from the filing
On November 26, 2024, the Company engaged BDO USA, P.C. (“BDO”) as the Company’s independent registered public accounting firm
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.